Advertisement

Topics

Companies Related to "Odonate Therapeutics, Inc." [Most Relevant Company Matches] - Page: 2 [Advanced Search Results] RSS

10:59 EDT 22nd October 2018 | BioPortfolio

Here are the most relevant search results for "Odonate Therapeutics, Inc." found in our extensive corporate database of over 50,000 company records.

Showing "Odonate Therapeutics" Companies 26–50 of 1,600+

Probably Relevant

Perlan Therapeutics

Perlan Therapeutics is an innovative developer of protein-based pharmaceuticals. The company's proprietary Multi-Valenceâ„¢ technology platform is the basis for the development of cost-effective protein-based therapeutics and diagnostic products that are characterized by increased binding avidity.


SteadyMed Therapeutics

SteadyMed Therapeutics, Inc. is a private, venture funded, Drug Delivery Therapeutics Company who are leaders in the development and commercialization of prefilled, size efficient and disposable patch pump technology. SteadyMed Therapeutics family of PatchPumps can be customized to deliver liquid drugs, including biologics, with a wide range of volumes and viscosities, in a consistent and cont...

Magenta Therapeutics Inc.

Magenta Therapeutics is a biotechnology company developing therapeutics to revolutionize bone marrow transplant for patients with autoimmune diseases, blood cancers and genetic diseases. By creating a platform focused on critical areas of transplant medicine, Magenta Therapeutics is pioneering an integrated approach to extend the curative power of bone mar...


Lava Therapeutics

Lava Therapeutics’ proprietary platform is focused on developing next generation γδ T cell engaging bispecific antibodies to treat cancer. Our first-in-class immuno-oncology approach activates Vγ9Vδ2 T cells upon binding to membrane-expressed tumor targets. Lava’s vision is to develop therapeutics for the curative treatment of cancer. Founde...

Rodin Therapeutics

Rodin Therapeutics is discovering and developing first in class therapeutics for cognitive disorders, applying unique insights into the role of epigenetics and best in class structural biology capabilities. Rodin closed a $12.9m Series A financing round in May 2014, and was co-founded in 2013 by Atlas Venture and Proteros Biostructures.

Calixa Therapeutics Inc.

Calixa Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of novel medicines for the treatment of infectious diseases. The company's initial focus is on developing novel antibiotics for use in the hospital setting. Calixa Therapeutics, which is privately held, is headquartered in San Diego and has operations in the San Francisco Bay Area. For ad...

Exonhit Therapeutics Incorporated

ExonHit Therapeutics is a functional genomics and drug discovery company that develops sophisticated and innovative gene-based therapeutics (Ready for Development Compounds - RDCs ) and diagnostic products by using its unique proprietary qualitative gene profiling technology, DATAS™, based on alternative splicing.

Viron Therapeutics Incorporated

Viron Therapeutics Inc. is an emerging biotechnology company developing novel anti-inflammatory therapeutics. Viron was founded in 1997 as a spin-off of The John P. Robarts Research Institute in London, Canada. The company has developed its unique platform of viral proteins into a pipeline of therapeutic products with a clear path to the marketplace.

OncoFusion Therapeutics, Inc.

OncoFusion Therapeutics is a privately-held company, which was founded in 2012 by Arul M. Chinnaiyan, M.D., Ph.D.; Shaomeng Wang, Ph.D., and Kenneth J. Pienta, M.D. to develop technology discovered at the University of Michigan. OncoFusion's mission is to discover and develop the next generation of personalized therapeutics for patients with genetically de...

vTv Therapeutics, Inc.

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv Therapeutics has a pipeline of clinical drug candidates for the treatment of Alzheimer’s disease, diabetes, inflammatory disorders and the pre...

Stem Cell Therapeutics Corp.

Stem Cell Therapeutics is a publicly listed Canadian biotechnology company headquartered in Calgary, Alberta. The company is focused on the development and commercialization of Therapeutics that control adult stem cells in the body. We leverage the experience and expertise of our efficient team with numerous contract relationships.

Centrexion Therapeutics Corp.

Centrexion Therapeutics Corp. is focused on advancing the treatment of chronic moderate to severe pain with one of the largest, exclusively pain-focused pipelines of non-opioid, non-addictive therapies in active development. Centrexion Therapeutics recognizes the needs of over a quarter of a billion people living with chronic pain worldwide, and aims to de...

Oraya Therapeutics Inc.

Oraya Therapeutics, Inc. is a privately held company developing innovative and non-invasive therapies for diseases of the eye. The company was founded in 2007. Its investors include Essex Woodlands Health Ventures, Domain Associates, Scale Venture Partners, and Carl Zeiss Meditec AG. More information about Oraya Therapeutics can be found at www.orayainc.co...

ADC Therapeutics Sarl

ADC Therapeutics (ADCT) is a Swiss-based oncology drug development company that specializes in the development of proprietary Antibody Drug Conjugates (ADCs) targeting major cancers such as breast lung, prostate, renal and blood. The Company’s ADCs are highly targeted drug constructs which combine monoclonal antibodies specific to particular types of ...

Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc. (CAPR), a publicly traded biotechnology company, is focused on the development of novel therapeutics to prevent and treat heart disease. The Company was formed through the November 2013 merger between Capricor, Inc., a privately held company whose mission is to improve the treatment of heart disease by commercializing cardiac st...

Silence Therapeutics AG

"Silence Therapeutics plc is a leading European RNAi company. RNA interference (RNAi), a Nobel Prize winning technology, is one of the most exciting areas of drug discovery today as it can selectively ""silence"" genes linked to the onset of disease, thus leading to the creation of a new class of therapeutic products, RNAi therapeutics."

Sarepta Therapeutics, Inc.

Sarepta Therapeutics is focused on developing first-in-class RNA-based therapeutics to improve and save the lives of people affected by serious and life-threatening rare and infectious diseases. The Company's diverse pipeline includes its lead program eteplirsen, for Duchenne muscular dystrophy, as well as potential treatments for some of the world's most ...

Kyn Therapeutics

Kyn Therapeutics is a biotechnology company advancing new immunometabolic therapies for cancer. A growing body of research indicates that key metabolites can exert broad suppressive or enhancing effects on the immune system through a complex network of cellular interactions, providing targets for new therapies that could significantly enhance patient respo...

Centrexion Therapeutics, Corp.

Centrexion Therapeutics, Corp. is focused on advancing the treatment of chronic moderate to severe pain with one of the largest exclusively pain-focused pipelines of non-opioid, non-addictive therapies in active development. Centrexion Therapeutics recognizes the needs of over a quarter of a billion patients living with chronic pain worldwide, and ...

Centrexion Therapeutics

Centrexion Therapeutics, Inc., is focused on developing and commercializing new, non-opioid and non-surgical treatments for moderate to severe chronic pain. Centrexion Therapeutics recognizes the needs of over a quarter of a billion patients living with chronic pain worldwide, and aims to develop new, safer and more effective therapies that overcome the li...

Neon Therapeutics

Neon Therapeutics is an immuno-oncology company focused on developing novel therapeutics leveraging neoantigen biology to treat cancer. A neoantigen-based product engine will allow Neon to develop further treatment modalities including next-generation vaccines and T cell therapies targeting both personalized as well as shared neoantigens. Neon Therapeutics...

Centrexion Therapeutics Corporation

Centrexion Therapeutics Corp. is focused on advancing the treatment of chronic moderate to severe pain with one of the largest exclusively pain-focused pipelines of non-opioid, non-addictive therapies in active development. Centrexion Therapeutics recognizes the needs of over a quarter of a billion people living with chronic pain worldwide, and aims ...

Admune Therapeutics

Admune Therapeutics, a clinical stage biotechnology company, was founded by a highly experienced team of scientists and business people with a proven track record in producing successful biomedical products. Admune Therapeutics is affiliated with Marine Polymer Technologies, Inc. (MPT), a provider of groundbreaking medical solutions focused in the areas of...

Highline Therapeutics

Highline Therapeutics is a biotech incubator established by Versant Ventures in New York City. Modeled on Blueline Bioscience in Toronto, Highline aims to identify and accelerate translational research and biotech company formation. Highline will partner with both local academic institutions and pharmaceutical companies to help bridge the gap between acade...

Rational Therapeutics, Inc

Who are we?Rational Therapeutics, Inc. (RTI) is a free-standing research laboratory located in Long Beach, CA. Founded in 1993 by Dr. Robert Nagourney, a prominent hematologist/oncologist, Rational Therapeutics pioneers intelligent cancer therapies that are scientifically tailored for each individual patient. What do we do?Rational Therapeutics develops and provides cancer therapy recommendations,...


More From BioPortfolio on "Odonate Therapeutics, Inc."

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks